...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Benzimidazole- and benzoxazole-based inhibitors of Rho kinase.
【24h】

Benzimidazole- and benzoxazole-based inhibitors of Rho kinase.

机译:基于苯并咪唑和苯并恶唑的Rho激酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Inhibitors of Rho kinase have been developed based on two distinct scaffolds, benzimidazoles, and benzoxazoles. SAR studies and efforts to optimize the initial lead compounds are described. Novel selective inhibitors of ROCK-II with excellent potency in both enzyme and cell-based assays were obtained. These inhibitors possess good microsomal stability, low cytochrome P-450 inhibitions and good oral bioavailability.
机译:已经基于两种不同的支架,苯并咪唑和苯并恶唑开发了Rho激酶抑制剂。描述了SAR研究和优化初始铅化合物的努力。获得了新型的ROCK-II选择性抑制剂,在酶和基于细胞的测定中均具有出色的效能。这些抑制剂具有良好的微粒体稳定性,低的细胞色素P-450抑制作用和良好的口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号